Pandemic-induced concerns about the international supply chain for face masks, pharmaceuticals, and other medical supplies are stoking renewed interest in tax incentives to lure manufacturers back to the U.S.
Lobbyists and advocates see the next pandemic relief package as a potential vehicle for new tax benefits for pharmaceutical and medical manufacturing companies. Negotiations aren’t expected to pick up again until July, but the conversation so far on this issue has focused on recently introduced House bills that could be included in a relief package.
Advocates point to the benefit a tax incentive could have on the economy of Puerto Rico, ...
Learn more about Bloomberg Tax or Log In to keep reading:
Learn About Bloomberg Tax
From research to software to news, find what you need to stay ahead.
Already a subscriber?
Log in to keep reading or access research tools.